≡ Menu

The Ampligen Chronicles by Kelvin Lord

After trying dozens of other treatments Kelvin Lord was on his last legs when he practically crawled in Dr. Lapps office in January 2010 for his first infusion of Ampligen, an immunomodulator under review by the FDA for ME/CFS, which was available to a only few doctors in the US.

Chart Kelvin’s progress as he describes, in sometimes side-splitting fashion, his experiences with Ampligen.

January

 

February

March

April

May

June

 

July

 

August

 

October

January, 2011

Sign the petition to get ME/CFS a research budget of $250 million a year!
There's a US petition and a global solidarity petition here with a long-term target of 50,000 signatures. Time we were on an equal per-patient funding basis with similar diseases!